StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
27
Publishing Date
2023 - 11 - 07
1
2023 - 10 - 26
1
2023 - 07 - 11
1
2023 - 05 - 09
2
2023 - 04 - 18
1
2022 - 08 - 01
1
2022 - 01 - 31
1
2022 - 01 - 27
1
2022 - 01 - 21
2
2022 - 01 - 18
1
2021 - 12 - 16
1
2021 - 11 - 01
2
2021 - 10 - 25
2
2021 - 10 - 04
1
2021 - 09 - 27
1
2021 - 06 - 07
1
2021 - 05 - 12
2
2021 - 03 - 05
2
2021 - 02 - 17
2
2021 - 01 - 08
1
Sector
Commercial services
27
Communications
63
Consumer durables
5
Consumer non-durables
10
Consumer services
5
Distribution services
6
Electronic technology
13
Finance
14
Finance and insurance
3
Health care and social assistance
7
Health services
32
Health technology
2876
Industrial services
2
Information
3
Manufacturing
213
Mining, quarrying, and oil and gas extraction
6
Miscellaneous
1
N/a
93
Non-energy minerals
2
Process industries
7
Producer manufacturing
11
Professional, scientific, and technical services
74
Real estate and rental and leasing
6
Retail trade
5
Technology services
27
Transportation and warehousing
2
Utilities
1
Wholesale trade
5
Tags
Acquisition
139
Agreement
58
America
75
Awards
142
Business
130
Cancer
94
Ceo
133
Ces
91
Cloud
66
Collaboration
82
Communications
69
Companies
94
Conference
701
Contract
122
Corporation
83
Covid
103
Covid-19
61
Deadline
154
Earnings
68
Education
137
Energy
115
Events
71
Expansion
58
Financial
418
Financial results
212
Gartner
297
Global
534
Group
303
Growing
63
Growth
412
Health
184
Management
165
Marathon
77
Market
700
Media
161
Meeting
64
N/a
9771
Nasdaq
63
Offering
196
One
84
Partnership
148
Platform
189
Program
100
Report
477
Research
292
Results
1220
Risk
102
Sales
77
Security
138
Service
86
Services
328
Set
140
Software
88
Solutions
225
Technology
313
Test
101
Trial
97
Update
95
Work
64
Year
285
Entities
Adaptive biotechnologies corporation
3
Altimmune, inc.
4
Alx oncology holdings inc.
2
Applied dna sciences, inc.
7
Arrival
2
Celcuity inc.
1
Intertek group plc
1
Microsoft corporation
1
Opgen, inc.
3
Progyny, inc.
3
Salarius pharmaceuticals, inc.
3
Symbols
ADPT
3
ALT
4
ALXO
2
APDN
7
ARVL
2
CELC
1
IKTSF
1
IKTSY
1
MSFT
1
OPGN
3
PGNY
3
SLRX
3
Exchanges
Nasdaq
27
Crawled Date
2023 - 11 - 07
1
2023 - 10 - 26
1
2023 - 07 - 11
1
2023 - 05 - 09
2
2023 - 04 - 18
1
2022 - 08 - 01
1
2022 - 01 - 31
1
2022 - 01 - 27
1
2022 - 01 - 21
2
2022 - 01 - 18
1
2021 - 12 - 16
1
2021 - 11 - 01
2
2021 - 10 - 25
2
2021 - 10 - 04
1
2021 - 09 - 27
1
2021 - 06 - 07
1
2021 - 05 - 12
2
2021 - 03 - 06
1
2021 - 03 - 05
1
2021 - 02 - 17
2
2021 - 01 - 09
1
Crawled Time
00:00
1
01:00
1
11:00
2
12:00
6
12:03
1
12:20
1
13:00
2
14:00
2
15:00
4
16:00
2
17:00
1
18:00
1
23:00
2
23:24
1
Source
www.adnas.com
3
www.biospace.com
8
www.fda.gov
1
www.globenewswire.com
11
www.prnewswire.com
1
www.progyny.com
3
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
sector :
Commercial services
tags :
Fda
save search
Salarius Completes FDA Type B Meeting for Seclidemstat Ewing Sarcoma Development Program
Published:
2023-11-07
(Crawled : 14:00)
- globenewswire.com
SLRX
A
|
$0.486
-2.8%
-2.88%
110K
|
Commercial Services
|
-37.5%
|
O:
11.25%
H:
4.49%
C:
-6.85%
fda
seclidemstat
meeting
program
Altimmune Granted Fast Track Designation by FDA for Pemvidutide for the Treatment of Non-Alcoholic Steatohepatitis (NASH)
Published:
2023-10-26
(Crawled : 12:00)
- globenewswire.com
ALT
|
$7.05
-6.25%
-6.67%
3.6M
|
Commercial Services
|
217.3%
|
O:
11.81%
H:
3.02%
C:
-12.45%
fda
granted
treatment
designation
Salarius Pharmaceuticals Receives FDA Clearance of SP-3164 Investigational New Drug Application to Begin a Phase 1 Clinical Trial in Relapsed/Refractory Non-Hodgkin Lymphoma Patients
Published:
2023-07-11
(Crawled : 12:20)
- globenewswire.com
SLRX
A
|
$0.486
-2.8%
-2.88%
110K
|
Commercial Services
|
-65.52%
|
O:
3.45%
H:
0.01%
C:
-15.33%
sp-3164
fda
drug
clearance
pharmaceuticals
application
trial
FDA Removes Partial Clinical Hold on Salarius Pharmaceuticals’ Phase 1/2 Clinical Trial with Seclidemstat in Patients with Ewing Sarcoma
Published:
2023-05-09
(Crawled : 12:00)
- globenewswire.com
SLRX
A
|
$0.486
-2.8%
-2.88%
110K
|
Commercial Services
|
-76.85%
|
O:
6.48%
H:
0.43%
C:
-21.3%
fda
seclidemstat
trial
Adaptive Biotechnologies Announces FDA Acceptance of Genentech’s Investigational New Drug Application for the First Neoantigen-Directed T-Cell Therapy Product in Oncology
Published:
2023-05-09
(Crawled : 11:00)
- globenewswire.com
ADPT
|
News
|
$2.435
-11.46%
-12.94%
3.3M
|
Commercial Services
|
-58.33%
|
O:
0.76%
H:
9.17%
C:
5.41%
fda
drug
t-cell
application
therapy
OpGen Submits De Novo request to the U.S. FDA for Unyvero Urinary Tract Infection Panel
Published:
2023-04-18
(Crawled : 12:00)
- globenewswire.com
OPGN
A
|
$0.621
-3.62%
-3.75%
130K
|
Commercial Services
|
-46.63%
|
O:
3.55%
H:
1.6%
C:
-16.0%
fda
infection
ALX Oncology’s Evorpacept Receives Fast Track Designation from FDA as First-Line Treatment for Head and Neck Squamous Cell Carcinoma
Published:
2022-08-01
(Crawled : 23:00)
- biospace.com/
ALXO
|
$16.08
10.97%
9.89%
2M
|
Commercial Services
|
49.69%
|
O:
2.07%
H:
1.42%
C:
-4.66%
treatment
fda
designation
cell carcinoma
fast track designation
Altimmune Announces FDA Clearance of Pemvidutide (ALT-801) IND for ObesityEnrollment in 48-week Phase 2 clinical trial expected to begin in Q1 2022
Published:
2022-01-31
(Crawled : 15:00)
- biospace.com/
ALT
|
$7.05
-6.25%
-6.67%
3.6M
|
Commercial Services
|
4.44%
|
O:
2.92%
H:
9.31%
C:
8.91%
alt-801
fda
obesity
phase 2
clearance
trial
fda clearance
ALX Oncology Receives U.S. FDA Orphan Drug Designation for Evorpacept for the Treatment of Patients with Gastric Cancer and Gastroesophageal Junction Cancer
Published:
2022-01-27
(Crawled : 23:00)
- globenewswire.com
ALXO
|
$16.08
10.97%
9.89%
2M
|
Commercial Services
|
0.91%
|
O:
-1.81%
H:
8.01%
C:
7.8%
treatment
fda
drug
orphan drug
cancer
designation
Applied DNA Submits Request for Emergency Use Authorization to FDA for Linea™ 2.0 COVID-19 Assay and Linea™ Unsupervised At-Home Sample Collection Kit
Published:
2022-01-21
(Crawled : 17:00)
- biospace.com/
ARVL
|
News
|
$0.49
0.37%
2.5M
|
Manufacturing
|
-90.75%
|
O:
-15.97%
H:
0.0%
C:
0.0%
APDN
|
$0.3295
-4.3%
-4.49%
84K
|
Commercial Services
|
-91.19%
|
O:
-0.77%
H:
0.0%
C:
0.0%
covid-19
fda
covid
authorization
merge
emergency use authorization
Request for FDA EUA for Linea™ 2.0 COVID-19 Assay, Linea™ Unsupervised At-Home Sample Collection Kit
Published:
2022-01-21
(Crawled : 16:00)
- adnas.com
ARVL
|
News
|
$0.49
0.37%
2.5M
|
Manufacturing
|
-90.75%
|
O:
-15.97%
H:
0.0%
C:
0.0%
APDN
|
$0.3295
-4.3%
-4.49%
84K
|
Commercial Services
|
-91.19%
|
O:
-0.77%
H:
0.0%
C:
0.0%
covid-19
fda
covid
Celcuity Receives FDA Fast Track Designation for Gedatolisib in HR+ / HER2- Metastatic Breast Cancer and Provides Corporate Update
Published:
2022-01-18
(Crawled : 13:00)
- biospace.com/
CELC
|
$16.96
-1.57%
-1.59%
120K
|
Commercial Services
|
49.18%
|
O:
-2.16%
H:
7.88%
C:
2.12%
fast track designation
fda
fast track
cel
fda fast track
cancer
breast cancer
designation
her2-
her2
metastatic breast cancer
Pharmaceutical Analytical Testing Outsourcing Market to grow by USD 3.21 bn| Increased Number of FDA-approved Manufacturing Facilities in Developing Nations to Boost Market Growth | 17000+ Technavio Reports
Published:
2021-12-16
(Crawled : 11:00)
- prnewswire.com
IKTSY
|
$59.99
-12.21%
1.9K
|
Professional, Scientific, and T...
|
-17.83%
|
O:
-0.1%
H:
0.0%
C:
-0.14%
fda
test
growth
COVID-19 Update: FDA Vaccine Approval, Booster Shots, and Trying to Conceive
Published:
2021-11-01
(Crawled : 18:00)
- progyny.com
PGNY
|
News
|
$32.71
-2.04%
-2.08%
640K
|
Commercial Services
|
-45.65%
|
O:
0.28%
H:
2.64%
C:
0.65%
covid
fda
vaccine
approval
covid-19
COVID-19 Update Webinar: FDA Vaccine Approval, Booster Shots, and Trying to Conceive
Published:
2021-11-01
(Crawled : 13:00)
- progyny.com
PGNY
|
News
|
$32.71
-2.04%
-2.08%
640K
|
Commercial Services
|
-45.65%
|
O:
0.28%
H:
2.64%
C:
0.65%
covid
fda
vaccine
approval
covid-19
APDN Submits FDA EUA Request for Linea™ SARS-CoV-2 Mutation Panel
Published:
2021-10-25
(Crawled : 14:00)
- adnas.com
APDN
|
$0.3295
-4.3%
-4.49%
84K
|
Commercial Services
|
-93.91%
|
O:
-1.77%
H:
4.32%
C:
2.88%
fda
sars-cov-2
Applied DNA Submits Request for Emergency Use Authorization to FDA for Linea™ SARS-CoV-2 Mutation Panel
Published:
2021-10-25
(Crawled : 12:00)
- biospace.com/
APDN
|
$0.3295
-4.3%
-4.49%
84K
|
Commercial Services
|
-93.91%
|
O:
-1.77%
H:
4.32%
C:
2.88%
fda
merge
sars-cov-2
emergency use authorization
OpGen Receives FDA Clearance for Acuitas® AMR Gene Panel
Published:
2021-10-04
(Crawled : 12:00)
- globenewswire.com
OPGN
A
|
$0.621
-3.62%
-3.75%
130K
|
Commercial Services
|
-76.91%
|
O:
24.37%
H:
2.31%
C:
-15.27%
fda clearance
fda
rapid diagnostics
clearance
Progyny Webinar: COVID-19 Update: FDA Vaccine Approval, Booster Shots, and Trying to Conceive
Published:
2021-09-27
(Crawled : 15:00)
- progyny.com
PGNY
|
News
|
$32.71
-2.04%
-2.08%
640K
|
Commercial Services
|
-47.36%
|
O:
0.46%
H:
0.0%
C:
-4.35%
covid
fda
vaccine
approval
covid-19
OpGen Submits Updated 510(k) Summary to FDA and Successfully Completes Move to New Headquarters in Maryland
Published:
2021-06-07
(Crawled : 12:00)
- globenewswire.com
OPGN
A
|
$0.621
-3.62%
-3.75%
130K
|
Commercial Services
|
-68.87%
|
O:
2.42%
H:
7.4%
C:
5.66%
fda
← Previous
1
2
Next →
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
News
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
News
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.